Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04EIE
|
||||
Former ID |
DNC009630
|
||||
Drug Name |
N5-(1-iminopent-3-enyl)-L-ornithine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529811] | ||
Structure |
Download2D MOL |
||||
Formula |
C10H19N3O2
|
||||
Canonical SMILES |
CC=CCC(=NCCCC(C(=O)O)N)N
|
||||
InChI |
1S/C10H19N3O2/c1-2-3-6-9(12)13-7-4-5-8(11)10(14)15/h2-3,8H,4-7,11H2,1H3,(H2,12,13)(H,14,15)/b3-2+/t8-/m0/s1
|
||||
InChIKey |
JUSNBVJTFYDFKR-SGJFDWMWSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Nitric-oxide synthase, brain | Target Info | Inhibitor | [529811] | |
BioCyc Pathway | Citrulline-nitric oxide cycle | ||||
NetPath Pathway | EGFR1 Signaling Pathway | ||||
PANTHER Pathway | CCKR signaling map ST | ||||
PathWhiz Pathway | Arginine and Proline Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.